pancreatic cancer
Cancer Prognoses Informed by Module-Based Approach, Study Finds
Researchers highlight patient survival and other prognostic clues that can be drawn from expression data and related module-based molecular analyses on several cancer types.
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
The collaboration will test retrospective samples from more than 200 patients to validate Biological Dynamics' platform.
The firm has commercialized its pancreatic cancer test and has its sights set on an ovarian cancer test launching in 2023.
Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
The firm will evaluate its epigenomic liquid biopsy test to detect pancreatic cancer among patients considered high-risk for the disease due to their diabetes.
Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test
Research companies Curta and Qure Healthcare will be conducting an economic modeling and physician behavior study, respectively.